Obermatt

Dr Martens

LSE:DOCS · GB00BL6NGV24
Textiles, Apparel & Luxury GoodsMedium

360

71
EV / EBIT50
Price / Owner Earnings13
Owner Earnings Yield27
Dividend Yield85
Price/Sales81
EV / Gross Profit70
Price/Book57
Return on Capital47
Cash Return on Capital31
Return on Equity28
EBIT Margin61
Gross Profitability82
Cash Conversion96
Accruals95
Owner Earnings Margin33
Sales growth21
Profit Growth57
Long-Term EPS Growth96
Owner Earnings Growth92
Reinvestment92
Price momentum35
Debt load38
Refinancing81
Debt Payback15
Liquidity56
Analyst ratings20
Opinion Changes50
Price Target Upside67
Market mood1
Value Creation14/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Dr Martens generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUK
IndustryTextiles, Apparel & Luxury Goods
SizeMedium
TypePublic Company
ExchangeLSE
Founded2020
ISINGB00BL6NGV24
Last UpdateApr 2, 2026

Description

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear under the company’s brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Business Segments The company operates through Direct-to-Co…

Analysis

Middle-of-the-road

Dr. Martens plc is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is expensive. You pay 25.3× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 9% yearly growth; analysts expect 24%. The price, in other words, assumes less than the experts do.

The trajectory is solid and the balance sheet is adequate. The company scores 14/20 on our value-creation score: strong value creator.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
66
2026

All-time high

66

Jun 2026

All-time low

61

Mar 2026

Average rank

64

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
81
Price/Earnings
44
Price/Book
57
Dividend Yield
85
Value (overall)
86

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Dr Martens with its peers
NIP Group
NMQ:NIPG
23
CountrySweden
IndustryEntertainment
SizeSmall
Full Stock Analysis →
SHL Telemedicine
SWX:SHLTN
24
CountryIsrael
IndustryHealth Care Providers & Services
SizeX-Small
Full Stock Analysis →
OKYO Pharma
NAQ:OKYO
40
CountryUK
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Nayax
TLV:NYAX
54
CountryIsrael
IndustryElectronic Equipment, Instruments & Components
SizeSmall
Full Stock Analysis →
Luceco
LSE:LUCE
99
CountryUK
IndustryElectrical Equipment
SizeSmall
Full Stock Analysis →
Lottomatica
MIL:LTMC
70
CountryItaly
IndustryHotels, Restaurants & Leisure
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →